Web page content
Trial - Protection in the progeny of flocks vaccinated against CAV
Protection of the progeny against chicken anemia virus infection from different vaccinated flocks was estimated by challenge experiments.
Experimental design
- Day-old chickens, both SPF and commercial chickens, derived from vaccinated breeding stock, were challenged with a Japanese isolate, a Dutch isolate and an isolate from the United States
- Challenge was done by intramuscular route.
- Two weeks later blood samples were taken for determination of the haematocrit
- Also at this stage post-mortem examination of thymus and bone marrow was carried out
- Protection was assessed by the mortality due to CAV, if the haematocrit value was below 27% or if the thymus atrophy or paleness of the bone-marrow was scored as 1 or 2, according to the score table below.
Post mortem examination
At post-mortem examination atrophy of the thymus and paleness of the bone-marrow were evaluated according to the following scoring system:
Scoring of thymus and bone marrow at post mortem
| 0 | No pathological changes |
|---|
| 1 | Slightly pale bone marrow / slightly atrophy of the thymus |
|---|
| 2 | Pale fatty bone marrow / severe thymus atrophy |
|---|
Origin of challenged 1 day-old chicks and serological status
Breeding stock vaccinated by: | Log2 VN titre at time of egg collection | Protection |
|---|
|
Intramuscular route | 11.6±1.0 | Yes | Subcutaneous route | 10.6±1.5 | Yes |
Wingweb route | 11.3±1.1 | Yes |
SPF | Negative | No |
Conclusion
The progeny from breeding stock with high VN titres against CAV (in this case induced by vaccination with Nobilis CAV P4) at time of egg collection was protected against a virulent challenge with 3 different isolates of CAV